Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 38676 - 38700 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Entinostat	Investigational	SYNPO	11346	upregulated	entinostat results in increased expression of SYNPO mRNA	5q33.1	A21035
Entinostat	Investigational	SYNRG	11276	downregulated	entinostat results in decreased expression of SYNRG mRNA	17q12	A21035
Entinostat	Investigational	SYT11	23208	downregulated	entinostat results in decreased expression of SYT11 mRNA	1q22	A21037
Entinostat	Investigational	SYT17	51760	downregulated	entinostat results in decreased expression of SYT17 mRNA	16p12.3	A21037
Entinostat	Investigational	SYT2	127833	upregulated	entinostat results in increased expression of SYT2 mRNA	1q32.1	A21037
Entinostat	Investigational	SYT7	9066	upregulated	entinostat results in increased expression of SYT7 mRNA	11q12.2	A21035
Entinostat	Investigational	SYT9	143425	upregulated	entinostat results in increased expression of SYT9 mRNA	11p15.4	A21035
Entinostat	Investigational	SYTL1	84958	upregulated	entinostat results in increased expression of SYTL1 mRNA	1p36.11	A21035
Entinostat	Investigational	SYTL2	54843	downregulated	entinostat results in decreased expression of SYTL2 mRNA	11q14.1	A21037
Entinostat	Investigational	TAC1	6863	downregulated	entinostat results in decreased expression of TAC1 mRNA	7q21.3	A21035
Entinostat	Investigational	TAC1	6863	upregulated	entinostat results in increased expression of TAC1 mRNA	7q21.3	A21037
Entinostat	Investigational	TAC3	6866	upregulated	entinostat results in increased expression of TAC3 mRNA	12q13.3	A21035
Entinostat	Investigational	TACC1	6867	upregulated	entinostat results in increased expression of TACC1 mRNA	8p11.22	A21037 A21035
Entinostat	Investigational	TAGLN	6876	downregulated	entinostat results in decreased expression of TAGLN mRNA	11q23.2	A21037
Entinostat	Investigational	TAGLN2	8407	upregulated	entinostat results in increased expression of TAGLN2 mRNA	1q23.2	A21035
Entinostat	Investigational	TAGLN3	29114	downregulated	entinostat results in decreased expression of TAGLN3 mRNA	3q13.2	A21037 A21035
Entinostat	Investigational	TANC1	85461	upregulated	entinostat results in increased expression of TANC1 mRNA	2q24.2	A21035
Entinostat	Investigational	TAP1	6890	upregulated	entinostat results in increased expression of TAP1 mRNA	6p21.32	A21035
Entinostat	Investigational	TAP2	6891	upregulated	entinostat results in increased expression of TAP2 mRNA	6p21.32	A21035
Entinostat	Investigational	TAPBPL	55080	upregulated	entinostat results in increased expression of TAPBPL mRNA	12p13.31	A21035
Entinostat	Investigational	TARDBP	23435	downregulated	entinostat results in decreased expression of TARDBP mRNA	1p36.22	A21037
Entinostat	Investigational	TARS	6897	upregulated	entinostat results in increased expression of TARS mRNA	5p13.3	A21037
Entinostat	Investigational	TBC1D24	57465	downregulated	entinostat results in decreased expression of TBC1D24 mRNA	16p13.3	A21035
Entinostat	Investigational	TBC1D30	23329	downregulated	entinostat results in decreased expression of TBC1D30 mRNA	12q14.3	A21037
Entinostat	Investigational	TBC1D8	11138	downregulated	entinostat results in decreased expression of TBC1D8 mRNA	2q11.2	A21037

Displaying entries 38676 - 38700 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability